Comparing HIV-1 Subtype C and B Resistance Profiles
Author Information
Author(s): Nauwelaers David, Van Houtte Margriet, Winters Bart, Steegen Kim, Van Baelen Kurt, Chi Ellen, Zhou Mimi, Steiner Derek, Bonesteel Rachelle, Aston Colin, Stuyver Lieven J.
Primary Institution: Virco BVBA, Beerse, Belgium
Hypothesis
Can the drug resistance profile of an HIV-1 subtype C GPRT amplicon be accurately assessed when introduced into an HIV-1 subtype B backbone?
Conclusion
The study found that the resistance profiles of HIV-1 subtype C and B were similar for most drugs tested, despite differences in viral kinetics.
Supporting Evidence
- Functional, infectious HIV-1 subtype C viruses were generated.
- The rate of infection for subtype C viruses was slower than for subtype B.
- Drug resistance profiles were similar in both subtype backbones.
- Some differences in drug resistance were statistically significant.
Takeaway
Researchers created a synthetic version of HIV-1 subtype C to see how it responds to drugs compared to subtype B, and they found that both types behave similarly in terms of drug resistance.
Methodology
The study involved constructing an HIV-1 subtype C backbone, generating recombinant viruses, and comparing their drug resistance profiles to those of subtype B.
Potential Biases
Potential bias due to the involvement of employees from companies that commercialize HIV drug resistance testing technology.
Limitations
The study was limited by the small number of samples tested and the focus on specific drug classes.
Participant Demographics
Eight HIV-1 clinical plasma samples from patients infected with subtype C.
Statistical Information
P-Value
0.031, 0.043, 0.033, 0.0041, 0.002
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website